CEimpact

Cardiovascular Risk: Do Omega-3 Fatty Acids REDUCE-IT?

Overview / Abstract:	Recently, an emergence of non-statin alternatives including omega-3 fatty acid-based products have demonstrated reduction in important cardiovascular endpoints. Where do these agents fit in patient care? Join us this month for our Journal Club discussion on how icosapent ethyl compares to other non-statin alternatives and previous literature examining use of omega-3 fatty acids.
Expiration	Aug 12, 2023
Discipline(s)	Pharmacy CPE
Format	Online, Webinar / Webcast / Video
Cost	$9.00
Credits / Hours	0.10
Accreditation	ACPE
Presenters / Authors / Faculty	Matthew Cantrell, PharmD, BCPS Clinical Associate Professor University of Iowa College of Pharmacy
Keywords / Search Terms	CEI Impact CEI Impact CEI ce, live, cholesterol lowering agents, litl, l2l, login to learn, log-in to learn, journal club, cholesterol, hypercholesterolemia, april journal club, april journal, journal club cardio, reduce, reduce it, reduce-it, coles, chol, cholesterol lowering, lowering cholesterol, cholest, fish oil, fishoil, fatty acid, omega 3, omega 3 fatty acid, omega3, omega-3

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map